Sequelae of GH Treatment in Children with PWS

Pediatr Endocrinol Rev. 2016 Dec;14(2):138-146. doi: 10.17458/PER.2016.TDM.SequelaeofGH.

Abstract

More than 15 years after rGH was granted marketing authorization for children with PWS, a review of the sequelae, side effects and safety issues of rGH therapy is timely. The publications on issues concerning respiratory function, glucose metabolism, fat mass, and scoliosis at baseline and with rGH treatment are herein presented. We discuss the impact of rGH side effects, make proposals to prevent or treat them, and emphasise the remaining questions and perspectives. As a whole, the benefit /risk ratio is positive, although questions are raised about the role of GH in premature pubarche and its long-term effects, particularly the potential long-term oncogenic risk. The organisation of care in dedicated or reference centres at the national and European level will facilitate the collection and analysis of data and serve as a paradigm for long-term follow-up.

Keywords: Diabetes mellitus; Growth hormone; Impaired glucose tolerance; Safety; Sleep-related disordered breathing.

Publication types

  • Review

MeSH terms

  • Body Composition / drug effects
  • Bone Density / drug effects
  • Child
  • Drug-Related Side Effects and Adverse Reactions
  • Human Growth Hormone / adverse effects*
  • Human Growth Hormone / therapeutic use
  • Humans
  • Prader-Willi Syndrome / drug therapy*
  • Prader-Willi Syndrome / epidemiology

Substances

  • Human Growth Hormone